Lung safety review delays FDA decision on United’s Tyvaso DPI ntaylor Tue, 03/01/2022 – 09:40
Category: Uncategorized
With Bayer’s new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long? aliu […]
Gilead’s HIV prospect lenacapavir hits FDA approval snag amid vial compatibility concerns fkansteiner Tue, 03/01/2022 – 10:48
FibroGen’s roxadustat safety mess draws SEC scrutiny as AstraZeneca-partnered anemia drug remains in limbo aliu Tue, 03/01/2022 – […]
The government needs to get tougher on public health and put more focus on interventions at the population […]
Appleby has picked up something of a poisoned chalice in predicting GP workforce requirements.1 His article appears in […]
We, Russian doctors, nurses, and paramedics, strongly oppose the military actions carried out by Russian armed forces on […]
Thousands of Russian doctors and other healthcare workers have signed an open letter to Vladimir Putin urging him […]
I spent many years as a medical teacher attempting to coach students in the art of empathy. Some […]
